Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12570982 | Altering gene expression in modified T cells and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-14 | 0 | 31 |
| 12570959 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-03-10 | 2042-08-30 | 0 | 31 |
| 12570963 | Gene therapies for lysosomal disorders | 🖼🧊📄§ | 2026-03-10 | 2043-04-11 | 0 | 31 |
| 12569548 | RNA construct | 🖼🧊📄§ | 2026-03-10 | 2040-06-18 | 0 | 31 |
| 12569403 | Capsule with reduced powder leakage | 🖼🧊📄§ | 2026-03-10 | 2040-12-03 | 0 | 31 |
| 12570684 | DPAGT1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors | 🖼🧊📄§ | 2026-03-10 | 2041-06-30 | 0 | 31 |
| 12570634 | Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-26 | 0 | 31 |
| 12569445 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-11-13 | 0 | 31 |
| 12571812 | Parallel cell processing method and facility | 🖼🧊📄§ | 2026-03-10 | 2043-12-06 | 0 | 31 |
| 12569449 | Cationic lipid compound, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-03-30 | 0 | 31 |
| 12569485 | SMARCA inhibitors and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-23 | 0 | 31 |
| 12569474 | Compositions and methods for treating anemia | 🖼🧊📄§ | 2026-03-10 | 2043-11-16 | 0 | 31 |
| 12570767 | Sequences of anti-ecto-5′-nucleotidase antibodies | 🖼🧊📄§ | 2026-03-10 | 2042-05-27 | 0 | 31 |
| 12570665 | Compositions comprising fullerenyl mesochlorin nano-photosensitizers with covalently bound antibiotics and their uses in combination therapy | 🖼🧊📄§ | 2026-03-10 | 2040-06-09 | 0 | 31 |
| 12570692 | Oligopeptide linker intermediate and preparation method thereof | 🖼🧊📄§ | 2026-03-10 | 2042-11-01 | 0 | 31 |
| 12570722 | Single alpha chain collagens | 🖼🧊📄§ | 2026-03-10 | 2043-10-26 | 0 | 31 |
| 12569361 | Devices and methods to treat and prevent diverticulitis | 🖼🧊📄§ | 2026-03-10 | 2041-02-25 | 0 | 31 |
| 12569458 | Method to deliver antifibrinolytic drugs to mitigate damage to the brain caused by concussive impact | 🖼🧊📄§ | 2026-03-10 | 2043-01-09 | 0 | 31 |
| 12570597 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-08-09 | 0 | 31 |
| 12569470 | Vasodilator and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12569515 | Gold-containing agents for the treatment of lung infections | 🖼🧊📄§ | 2026-03-10 | 2041-03-15 | 0 | 31 |
| 12569821 | Microcapsules coated with a polysuccinimide derivative | 🖼🧊📄§ | 2026-03-10 | 2041-03-15 | 0 | 31 |
| 12569534 | Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria | 🖼🧊📄§ | 2026-03-10 | 2039-07-30 | 0 | 31 |
| 12569454 | Nucleophilic chemicals useful in the treatment of cisplatin-induced sensory neuropathy and ototoxicity | 🖼🧊📄§ | 2026-03-10 | 2039-12-27 | 0 | 31 |
| 12569452 | Ophthalmic compositions comprising F6H8 | 🖼🧊📄§ | 2026-03-10 | 2044-02-12 | 0 | 31 |
| 12569430 | Biodegradable implant including naltrexone | 🖼🧊📄§ | 2026-03-10 | 2042-04-01 | 0 | 31 |
| 12569495 | Inhibitors of porcine reproductive and respiratory syndrome virus | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12569493 | Treatment of chemosensory dysfunction from a coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-03-19 | 0 | 31 |
| 12569512 | Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury | 🖼🧊📄§ | 2026-03-10 | 2042-05-13 | 0 | 31 |
| 12570980 | Methods and compositions for treating inflammatory conditions associated with infectious disease | 🖼🧊📄§ | 2026-03-10 | 2045-04-02 | 0 | 31 |
| 12569482 | Methods and compositions for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-10 | 2040-10-02 | 0 | 31 |
| 12569524 | Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state | 🖼🧊📄§ | 2026-03-10 | 2039-10-21 | 0 | 31 |
| 12569484 | Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12571027 | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF | 🖼🧊📄§ | 2026-03-10 | 2044-09-10 | 0 | 31 |
| 12569491 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-10 | 2045-01-31 | 0 | 31 |
| 12569543 | Semaglutide in cardiovascular conditions | 🖼🧊📄§ | 2026-03-10 | 2037-04-28 | 0 | 31 |
| 12569556 | Aluminum based adjuvants for tolerogenic vaccination | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12570670 | Compounds, compositions, and methods for treating fibrosis | 🖼🧊📄§ | 2026-03-10 | 2040-01-30 | 0 | 31 |
| 12570686 | Chemical structures that control metabolic elimination of aminosterols | 🖼🧊📄§ | 2026-03-10 | 2045-02-18 | 0 | 31 |
| 12569416 | Oil-in-water emulsified cosmetic | 🖼🧊📄§ | 2026-03-10 | 2039-12-20 | 0 | 31 |
| 12570728 | Combinations of antibodies and bispecific antibodies comprising antigen-binding specifically recognizing Pseudomonas PcrV and Psl | 🖼🧊📄§ | 2026-03-10 | 2041-11-18 | 0 | 31 |
| 12569048 | Method for removing hair from an area of skin | 🖼🧊📄§ | 2026-03-10 | 2043-10-24 | 0 | 31 |
| 12569461 | Therapeutic supplement | 🖼🧊📄§ | 2026-03-10 | 2043-08-19 | 0 | 31 |
| 12570733 | Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules | 🖼🧊📄§ | 2026-03-10 | 2042-06-30 | 0 | 31 |
| 12569420 | Composition comprising a particular oxidation dyeing base and at least two particular couplers | 🖼🧊📄§ | 2026-03-10 | 2041-12-16 | 0 | 31 |
| 12569427 | Makeup application method | 🖼🧊📄§ | 2026-03-10 | 2041-03-22 | 0 | 31 |
| 12570675 | Boronic acid compounds | 🖼🧊📄§ | 2026-03-10 | 2041-12-10 | 0 | 31 |
| 12570744 | Bispecific PD-1 and TIGIT binding proteins and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2044-02-14 | 0 | 31 |
| 12570622 | Therapeutic compounds | 🖼🧊📄§ | 2026-03-10 | 2042-11-29 | 0 | 31 |
| 12570614 | Phenyl amino pyrimidine compounds and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-04-20 | 0 | 31 |